Answers are grounded in this paper and cite their sources.
Cohort analysis reveals baseline inflammation predicts long-term risk of hospitalized VTE, indicating its clinical importance.
Venous thromboembolism (VTE) is a major vascular disease associated with substantial morbidity and mortality worldwide. Chronic low-grade systemic inflammation has been implicated in thrombus formation, yet its long-term association with incident VTE in the general population remains incompletely understood using routinely available biomarkers. We conducted a prospective cohort analysis of 473,717 participants from the UK Biobank to examine associations between baseline inflammatory biomarkers—including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI)—and incident hospitalized VTE. Inflammatory biomarkers were measured at baseline (2006–2010), and hospitalized VTE events were identified through linked hospital inpatient records using ICD-10 codes during follow-up. Cox proportional hazards regression models were used to estimate associations between inflammatory biomarkers and incident hospitalized VTE, with hazard ratios (HRs) calculated per unit increase based on baseline blood cell counts. During a median follow-up of 14.6 years, 13,709 participants developed hospitalized VTE, including 12,291 pulmonary embolism events, 1,168 deep vein thrombosis events, and 250 cases with both conditions. Higher baseline neutrophil count, monocyte count, and NLR were independently associated with incident hospitalized VTE after multivariable adjustment. Associations for composite indices such as SII and SIRI were attenuated after accounting for shared cellular components and clinical confounders. The observed VTE incidence was lower than population-based estimates, reflecting reliance on hospital inpatient records that preferentially capture clinically significant events. Baseline low-grade systemic inflammation is associated with the long-term risk of hospitalized VTE in the general population. Despite conservative event ascertainment, routinely measured inflammatory biomarkers—particularly NLR and monocyte count—remained independently associated with future events, supporting their potential role as complementary markers for long-term VTE risk stratification and prevention. • Baseline low-grade systemic inflammation is associated with long-term risk of venous thromboembolism • Higher neutrophil count, monocyte count, and neutrophil-to-lymphocyte ratio predict incident VTE • Associations persist up to 10–15 years after baseline assessment • Composite inflammatory indices attenuate after adjustment for shared cellular components • Routine blood-based inflammatory markers may complement long-term VTE risk stratification
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: